Frequency of M. tuberculosis strains with different drug resistance profiles among pulmonary tuberculosis patients in the Kyrgyz Republic in 2016
https://doi.org/10.21292/2075-1230-2018-96-9-31-37
Abstract
The article presents the analysis of multiple drug resistant tuberculosis (MDR TB) prevalence among new and previously treated cases in the Kyrgyz Republic in 2016. The part of MDR TB among new cases makes 21.9%, among relapses – 49.2%, and among previously treated cases – 64%. 52.2% of new cases are susceptible to anti-tuberculosis drugs, as 28.1% of relapses and 17.8% of previously treated patients.
About the Authors
A. A. Toktogonovа
National Phthisiology Center
Kyrgyzstan
Kyrgyzstan
Atyrkul A. Toktogonova - Candidate of Medical Sciences, Senior Researcher.
90a, Akhunbaeva St., Bishkek, 720020, Phone: +996-771-110-117
E. A. Mаlyukovа
National Phthisiology Center
Kyrgyzstan
Kyrgyzstan
Yekaterina A. Malyukova - Head of Republican Information and Epidemiology Center.
90a, Akhunbaeva St., Bishkek, 720020, Phone: +996-771-052-245
K. M. Mukаnbаev
National Phthisiology Center
Kyrgyzstan
Kyrgyzstan
Kasymbek Mukanbaev - Doctor of Medical Sciences, Senior Researcher.
90a, Akhunbaeva St., Bishkek, 720020, Phone: +996-770-738-487
T. I. Petrenko
Novosibirsk Tuberculosis Research Institute
Russian Federation
Russian Federation
Tatiana I. Petrenko - Doctor of Medical Sciences, Head Researcher.
81a, Okhotskaya St., Novosibirsk, 630040, Phone: +7 (383) 203-83-58
T. A. Kolpаkovа
Novosibirsk State Medical University
Russian Federation
Russian Federation
Tatiana A. Kolpakova - Doctor of Medical Sciences, Associate Professor at FPK and PPS Tuberculosis Control Department.
81a, Okhotskaya St., Novosibirsk, 630040, Phone: +7 (383) 203-78-25References
1. Dymova M.А., Аlkhovik O.I., Cherednichenko А.G., Khrapov E.А., Petrenko T.I., Filipenko M.L. Genotyping of Mycobacterium tuberculosis isolates with extensive drug resistance. Vestn. Tyumen. Gosudarstvennogo Universiteta, Seriya: Biologiya, Klinicheskaya Meditsina, 2013, vol. 11, no. 1, pp. 110-117. (In Russ.)
2. Isakova Zh.T., Goncharova Z.K., Аldashev А.А. Characteristics of drug resistance profiles of rifampycin resistant strains of M. tuberculosis to other anti-tuberculosis drugs of the first line. Probl. Tub., 2008, no. 11, pp. 39-42. (In Russ.)
3. Toktogonova A.A. Prevalence of MDR TB in the Kyrgyzstan Republic. Phthisiopulmonology, 2013, no. 1 (22), pp. 29-32. (In Russ.)
4. Joncevska M., Kurbaniyazova G., Kalon S. et al. Use of GeneXpert to support fully ambulatory treatment of TB in Kyrgyzstan. Int. J. Tuberc. Lung Dis., 2015, vol. 19, no. 12, pp. 362. Available at: http://capetown.worldlunghealth.org/Abstract_Book_2015-Web.pdf (Accessed as of 08.11.2016).
5. Kurbaniyazova G., Joncevska M., Kalon S., Kalmambetova G., Mohr T., Toktogonova A., Takieva K., Monirul K., Islam M., Luelmo F. Results of Xpert-MTB/RIF implementation in Kyrgyzstan. Int. J. Tuberc. Lung Dis., no. 21 (3), pp. 333-337. Q 2017. The Union. Available at: http://dx.doi.org/10.5588/ijtld.16.0191(Accessed as of 11.01.2018).
6. Tuberculosis surveillance and monitoring in Europe. Surveillance reports. WHO, 2015, 93 p.
7. Tuberculosis, WHO, Fact sheet № 104 Reviewed. March 2016. Available at http://www.who.int/tb/publications/factsheets/en/ (Accessed as of 28.02.2016).
Review
For citations:
Toktogonovа A.A., Mаlyukovа E.A., Mukаnbаev K.M., Petrenko T.I., Kolpаkovа T.A. Frequency of M. tuberculosis strains with different drug resistance profiles among pulmonary tuberculosis patients in the Kyrgyz Republic in 2016. Tuberculosis and Lung Diseases. 2018;96(9):31-37. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-9-31-37
Views:
758
Email this article 